2020
Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report
Mazzone PJ, Gould MK, Arenberg DA, Chen AC, Choi HK, Detterbeck FC, Farjah F, Fong KM, Iaccarino JM, Janes SM, Kanne JP, Kazerooni EA, MacMahon H, Naidich DP, Powell CA, Raoof S, Rivera MP, Tanner NT, Tanoue LK, Tremblay A, Vachani A, White CS, Wiener RS, Silvestri GA. Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report. Radiology Imaging Cancer 2020, 2: e204013. PMID: 33778716, PMCID: PMC7233408, DOI: 10.1148/rycan.2020204013.Peer-Reviewed Original ResearchConceptsLung cancer screeningStage I non-small cell lung cancerNon-small cell lung cancerCell lung cancerCancer screeningLung nodule evaluationConsensus statementLung nodulesLung cancerClinical stage I non-small cell lung cancerNodule evaluationAnnual lung cancer screeningHigh-risk lung nodulesLung cancer screening programsCurrent guideline recommendationsCancer screening programsPatient-related factorsCommon clinical scenariosCoronavirus disease 2019Balance of benefitsIndividual patient careCOVID-19 pandemicPotential exposureGuideline recommendationsSurveillance imaging
2010
Imaging Requirements in the Practice of Pulmonary Metastasectomy
Detterbeck FC, Grodzki T, Gleeson F, Robert JH. Imaging Requirements in the Practice of Pulmonary Metastasectomy. Journal Of Thoracic Oncology 2010, 5: s134-s139. PMID: 20502248, DOI: 10.1097/jto.0b013e3181dcf64d.Peer-Reviewed Original ResearchConceptsHelical CT scansPulmonary metastasectomyCT scanThin-section scanningBetter patient selectionPrimary imaging modalityPositron emission tomographyPulmonary metastasesFurther metastasesMetastatic sitesPatient selectionSurveillance imagingPeriod of observationEmission tomographyMetastasisImaging modalitiesMetastasectomyReconstruction thicknessPatientsTomographyScansOptimal intervalFollowPalpationWeeks